Effective anti-tumor immunity is induced in mice utilizing RNA-pulsed epidermal cells (EC) for in vivo immunization or by injecting RNA intradermally into nave mice. A vaccine comprising total cell RNA and a pharmaceutically acceptable carrier for inducing an immune response to reduce or prevent the occurrence of a tumor.

 
Web www.patentalert.com

< Pharmaceutical composition comprising factor VIIa and anti-TFPI

< Materials for soft tissue augmentation and methods of making and using same

> Melanoma vaccine and methods of making and using same

> Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins

~ 00247